Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
11,137 total articles
Crexendo is a small, capital-efficient cloud telecommunications and software business that has doubled off its 52-week low and is showing free cash flow generation, a clean balance sheet and a compact float. Those attributes support a high-conviction long trade targeting meaningful upside over 180 trading days, while acknowledging elevated valuatio…
HP reported a solid Q2 with revenue of $14.41B and EPS of $0.86, yet shares trade at just ~9.4x earnings and yield ~4.6%. Rising memory costs justify caution, but the company is a free-cash-flow generator ($2.88B last twelve months) with an enterprise value of ~$29.9B. This trade idea argues the risk/reward favors a mid-term long while treating the…
Eli Lilly is riding a powerful wave from its GLP-1 franchise and now appears to be extending its R&D muscle into infectious diseases while retatrutide posts another Phase 3 win. The combination of blockbuster sales momentum, a deep cash-generating business and new pipeline catalysts creates a buy-able setup on a disciplined pullback. Valuation is r…
Nano Labs is a microcap fabless semiconductor and AI-compute specialist that pivoted into crypto reserves while trimming opex. At $2.48 and a $57M market cap, the stock offers asymmetric upside if recent product and North American AI infrastructure initiatives gain traction. This is a high-risk, mid-term trade idea: enter at $2.48, stop $1.85, targ…
InMode (INMD) looks mispriced for a credible operational recovery. The company sits on a large cash position, generates meaningful free cash flow, and trades well below levels implied by strategic interest. I lay out a long trade with entry, stop and target geared to a multi-quarter turnaround through 2026 and into 2027.
Q32 Bio (QTTB) is a clinical-stage biotech focused on immune rebalancing through IL-7/TSLP receptor and complement programs. With a market cap near $200M, a lean balance sheet, and an upcoming mid-2026 data cadence tied to bempikibart advancement, we rate QTTB Buy. Our trade plan: enter at $11.81, stop $9.00, target $22.00 over a long-term horizon …
Celestica combines contract-manufacturing scale, recent outsized AI revenue growth, and a strategic AMD partnership that positions it as one of the purer public plays on rack-scale AI infrastructure. The shares trade with solid fundamentals but a demanding multiple. This trade idea lays out an entry at $355.72, a stop at $320.00 and a $420.00 targe…
Novo Nordisk (NVO) is pricing in persistent GLP-1 share loss and a protracted growth slowdown. Recent regulatory wins (CHMP recommendation for Wegovy 7.2 mg single-dose pen and an oral semaglutide approval recommendation) and still-healthy fundamentals argue for a tactical long. The trade targets a recovery toward $65 over the next 180 trading days…
Meta is no longer just a social-media advertiser. The company is re-rating into AI infrastructure, subscriptions and potentially cloud services. With a market cap near $1.60T, a 23x P/E and growing free cash flow, the stock offers asymmetric upside if AI monetization accelerates — but the path is capital-intensive and execution-dependent. This trad…
Microsoft is offering a rare Growth-at-a-Reasonable-Price setup near $415 after a pullback from last year's highs. Strong profitability (ROE 30%), $72.9B in free cash flow, low leverage, and a PE in the mid-20s support a long bias. Trade plan with entry at $412.84, stop at $398.00, and primary target $470.00 on a 180-trading-day horizon.
Japan Tobacco (JAPAY) is a beaten-but-not-broken global tobacco incumbent trading on the OTC market. The stock sits near its 20/50-day moving averages, offers a 2.84% yield and a mid-teens P/E, making it an attractive, lower-volatility swing trade. Entry at $19.00, stop at $18.00 and a target of $20.60 balances risk with a clear technical upside.
Advanced Micro Devices is moving from a GPU-centric rally to a broader AI platform play that includes CPUs, accelerators, networking and custom silicon. The stock is richly valued - market cap ~$808B and a P/E north of 160 - but fundamentals and visible catalysts (Q1 strength, a $10B Taiwan commitment, rising AI capex) support further upside. This …
The Beachbody Company (BODI) looks like an actionable swing trade: the shares trade near $9.80 after a pullback from the $16.87 52-week high, but the company still generates meaningful free cash flow ($13.98M) and carries an EV/EBITDA of ~2.9 and a P/E of ~13.9. This setup pairs a valuation gap with improving fundamentals, a manageable balance shee…
DocuSign's shares have been punished with the rest of software, and vocal shorts are piling in. But the company is converting new AI-driven products into real recurring revenue, is cash-generative, and trades at multiples that leave room for upside if execution holds. This trade plan buys that survivability at $49 and targets a clear re-rating over…
BlackBerry's QNX has real traction as an embedded OS for regulated edge AI - partnerships with Nvidia and recent automotive wins give the company a path to meaningfully higher software annuity revenue. The stock looks expensive on trailing multiples today, but a combination of backlog conversion, higher gross margins and recurring SaaS-like revenue…
American Express (AXP) reported a strong quarter and still looks worth owning at $312.59. The company’s high return on equity, robust free cash flow ($14.3B) and premium closed-loop model support a buy rating. This trade idea lays out an actionable swing trade with entry, stop and target, plus the key catalysts and risks to monitor over the next 45…
PSH is an actively managed short-duration high-yield ETF trading near $50.10 with a 30-day SEC yield of 5.27% and a modest market cap of $161.6M. The fund's strategy - sub-investment-grade credit with an average portfolio duration of ~3 years or less - gives investors a way to pick up yield while limiting interest-rate sensitivity. This idea is a m…
AST SpaceMobile (ASTS) has gone from penny-stock obscurity to a headline-grabbing space telecom name. With FCC approvals, sizable short interest, strong momentum and multiple commercial partnerships in hand, ASTS is a tradeable long for active investors willing to accept elevated risk. This idea lays out an entry at $129.59, a stop at $90.00 and a …
I am upgrading Advanced Micro Devices (AMD) to a tactical long. Execution across CPUs, GPUs and accelerators appears steadier, the company is demonstrating improving mix and margins, and risk-reward at current levels looks attractive for a swing trade. The trade plan below gives concrete entry, stop and target with timeframes and reasons for what w…
Micron and SK Hynix's recent moves have legitimized a fresh leg of AI infrastructure buying. Seagate sits squarely in that flow with new product wins, sizable free cash generation and hyperscaler demand. Valuation is stretched versus historical averages, so this is a tactical, risk-managed buy: entry $872.00, target $980.00, stop $800.00, mid-term …
Super Micro Computer (SMCI) looks set to extend its rebound. Strong AI-driven sales, rising technicals and a crowded short book create a favorable setup for a mid-term long trade. The plan below balances upside potential with legal and margin risks through a clear entry, stop and target.
Nebius appears positioned to benefit from renewed enterprise spending on cloud modernization. This trade recommends a tactical long with tight risk control: enter at $6.20, stop at $4.90, and target $9.75 over a swing window. The idea rests on product traction, improving gross margins, and a market that often re-rates high-growth software on visibl…
National Energy Services Reunited (NESR) just locked material cementing work in Kuwait and North Africa and trades at a valuation that still leaves room for re-rating if contract momentum and margins hold. This trade proposes a mid-term long with disciplined stop loss and a clear target tied to a move above recent resistance.
<p>Freeport-McMoRan (FCX) is a high-quality copper (and gold) producer sitting on a diversified global asset base and generating meaningful free cash flow. The market punished the name after a Grasberg ramp delay and a guidance cut, but persistent structural demand for copper - driven by AI data centers and electrification - combined with Freeport'…
Rayonier (RYN) currently trades with a modest P/B (~1.17) and yields roughly 4.2%, while recent asset sales and a strategic merger create a credible path to cash returns and NAV re-rating. The trade: accumulate on weakness at $20.50, hold through near-term catalysts and a potential rerating over a mid-term window (45 trading days), with a stop at $…
